Neuren Pharmaceuticals Limited (ASX:NEU)
Australia
· Delayed Price · Currency is AUD
12.63
+0.95 (8.13%)
Mar 10, 2026, 1:19 PM AEST
Neuren Pharmaceuticals Ratios and Metrics
Market cap in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,479 | 2,357 | 1,588 | 3,178 | 1,001 | 475 | |
| Market Cap Growth | -15.70% | 48.44% | -50.04% | 217.33% | 110.87% | 222.46% | |
| Enterprise Value | 1,183 | 2,057 | 1,374 | 3,092 | 970 | 457 | |
| Last Close Price | 11.68 | 18.61 | 12.50 | 24.97 | 7.95 | 3.77 | |
| PE Ratio | 50.19 | 77.43 | 11.18 | 20.23 | 5442.54 | - | |
| Forward PE | 91.37 | 55.42 | 19.45 | 32.20 | 19.55 | - | |
| PS Ratio | 22.87 | 36.46 | 7.32 | 13.70 | 64.96 | 148.54 | |
| PB Ratio | 4.37 | 6.96 | 4.36 | 15.49 | 24.08 | 12.10 | |
| P/TBV Ratio | 4.37 | 6.96 | 4.36 | 15.49 | 24.08 | 12.10 | |
| P/FCF Ratio | 11.79 | 18.80 | - | 17.19 | 279.73 | - | |
| P/OCF Ratio | 11.79 | 18.79 | - | 17.18 | 278.25 | - | |
| EV/Sales Ratio | 18.29 | 31.82 | 6.34 | 13.33 | 62.94 | 142.84 | |
| EV/EBITDA Ratio | 53.60 | 93.25 | 7.67 | 15.52 | - | - | |
| EV/EBIT Ratio | 53.66 | 93.35 | 7.67 | 15.52 | - | - | |
| EV/FCF Ratio | 9.43 | 16.41 | - | 16.73 | 271.04 | - | |
| Net Debt / Equity Ratio | -0.87 | -0.87 | -0.61 | -1.11 | -0.97 | -0.94 | |
| Net Debt / EBITDA Ratio | -13.42 | -13.42 | -1.24 | -1.15 | 55.65 | 4.47 | |
| Net Debt / FCF Ratio | -2.36 | -2.36 | 19.70 | -1.24 | -11.22 | 3.69 | |
| Asset Turnover | 0.17 | 0.17 | 0.66 | 1.59 | 0.37 | 0.10 | |
| Quick Ratio | 74.40 | 74.40 | 8.69 | 5.68 | 24.59 | 47.58 | |
| Current Ratio | 76.60 | 76.60 | 8.73 | 5.78 | 25.77 | 49.87 | |
| Return on Equity (ROE) | 8.67% | 8.67% | 49.92% | 127.30% | 0.46% | -24.57% | |
| Return on Assets (ROA) | 3.66% | 3.66% | 34.05% | 85.52% | -1.10% | -15.83% | |
| Return on Invested Capital (ROIC) | 40.70% | 18.73% | 235.12% | - | -37.74% | -663.42% | |
| Return on Capital Employed (ROCE) | 6.50% | 6.50% | 49.20% | 97.10% | -1.80% | -21.00% | |
| Earnings Yield | 2.06% | 1.29% | 8.95% | 4.94% | 0.02% | -1.64% | |
| FCF Yield | 8.48% | 5.32% | -0.71% | 5.82% | 0.36% | -2.10% | |
| Buyback Yield / Dilution | 0.01% | 0.01% | -0.01% | -1.44% | -8.76% | -10.71% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.